Roberto Cuca - Feb 23, 2024 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
COO and CFO
Signature
/s/ Megan Smeykal, Attorney-in-fact
Stock symbol
TELA
Transactions as of
Feb 23, 2024
Transactions value $
-$19,690
Form type
4
Date filed
2/27/2024, 04:36 PM
Previous filing
Nov 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +29.2K +46.02% $0.00 92.7K Feb 23, 2024 Direct F1, F2
transaction TELA Common Stock Tax liability -$19.7K -2.79K -3.01% $7.07 89.9K Feb 23, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +42.7K $0.00 42.7K Feb 23, 2024 Common Stock 42.7K $7.07 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2 Includes 1,079 shares acquired under the Company's employee stock purchase plan on January 31, 2024.
F3 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
F4 The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.